Hokko Chemical IndustryHOKKO CHEMICAL INDUSTRY CO.,LTD.4992東証スタンダード化学FY ending Nov 2025, consolidated, J-GAAP
Out of every ¥100 of sales, about ¥10 is left as operating profit. Revenue changed +6.3% from the prior year, operating profit +8.2%.
Net margin × asset turnover = ROA; ROA × financial leverage = ROE
Denominators: average assets and average equity. Derived from reported values; ROE is shown only for positive profit and equity.
| Period | Net margin | Asset turnover | ROA | Financial leverage | ROE |
|---|---|---|---|---|---|
| 2021 | 7.3% | 0.77× | 5.6% | 1.87× | 10.5% |
| 2022 | 9.4% | 0.82× | 7.7% | 1.85× | 14.2% |
| 2023 | 8.2% | 0.72× | 6.0% | 1.89× | 11.3% |
| 2024 | 8.7% | 0.70× | 6.0% | 1.85× | 11.2% |
| 2025 | 9.1% | 0.69× | 6.2% | 1.86× | 11.6% |
Financial leverage can raise ROE; a higher value alone does not describe a company's overall condition.
Annual trends in tangible-asset ratios and goodwill balance.
Ratios are derived from reported values. Goodwill is shown only when separately reported; it is not inferred from combined intangible assets. Definition
Track R&D investment and how long operating capital remains tied up before sales turn into cash.
R&D is shown only for years with machine-readable disclosure. Days are estimates using year-end receivables, inventory and payables divided by annual revenue or cost of sales; financial companies are excluded.
| Item | FY ending Nov 2021 | FY ending Nov 2022 | FY ending Nov 2023 | FY ending Nov 2024 | FY ending Nov 2025 |
|---|---|---|---|---|---|
| Revenue | 40,287 | 44,864 | 45,227 | 46,195 | 49,125 |
| Cost of revenue | 29,784 | 32,853 | 33,671 | 34,125 | 36,412 |
| Gross profit | 10,503 | 12,011 | 11,556 | 12,070 | 12,713 |
| SG&A | 7,473 | 7,284 | 7,140 | 7,530 | 7,800 |
| Operating income | 2,865 | 4,727 | 4,417 | 4,540 | 4,913 |
| Pretax income | 3,939 | 5,792 | 5,389 | 5,560 | 6,220 |
| Income tax | 1,012 | 1,578 | 1,665 | 1,554 | 1,768 |
| Net income attributable to owners | 2,927 | 4,214 | 3,724 | 4,006 | 4,452 |
| Operating margin | 7.1% | 10.5% | 9.8% | 9.8% | 10.0% |
Year-end figures from filings. Unreported items are omitted. Interest-bearing debt excludes lease liabilities.
Each bar totals 100% of assets; other is the residual.
| Item | FY ending Nov 2021 | FY ending Nov 2022 | FY ending Nov 2023 | FY ending Nov 2024 | FY ending Nov 2025 |
|---|---|---|---|---|---|
| Cash and equivalents | ¥4.32B | ¥4.81B | ¥6.63B | ¥9.71B | ¥13.2B |
| Total assets | ¥52B | ¥57.6B | ¥67.5B | ¥65.3B | ¥77.6B |
| Net assets | ¥34.2B | ¥38.2B | ¥46.8B | ¥46.2B | ¥52.9B |
| Share capital | ¥3.21B | ¥3.21B | ¥3.21B | ¥3.21B | ¥3.21B |
| Trade receivables | ¥11.3B | — | — | — | — |
| Property, plant and equipment | ¥9.15B | ¥11.7B | ¥11B | ¥10.6B | ¥11.9B |
| Intangible assets excluding goodwill | ¥705M | ¥615M | ¥665M | ¥590M | ¥488M |
| Goodwill | ¥285M | ¥246M | ¥207M | ¥168M | ¥129M |
| Investment securities | ¥9.38B | ¥9.79B | ¥17B | ¥12.3B | ¥18.3B |
| Current assets | ¥32.5B | ¥34.7B | ¥37.7B | ¥40.7B | ¥45.3B |
| Current liabilities | ¥12.1B | ¥14.6B | ¥12.6B | ¥12.5B | ¥17.1B |
| Trade payables | ¥6.38B | ¥5.55B | ¥5.93B | ¥5.61B | ¥8.18B |
| Short-term borrowings | ¥225M | ¥97M | — | — | — |
| Long-term borrowings | ¥1.4B | — | ¥1B | ¥1B | — |
| Total liabilities | ¥17.8B | ¥19.3B | ¥20.7B | ¥19.1B | ¥24.7B |
| Equity attributable to owners of parent | ¥27.8B | ¥31.5B | ¥34.6B | ¥37.2B | ¥39.5B |
| Retained earnings | ¥23.3B | ¥27B | ¥30.1B | ¥33.3B | ¥35.1B |
| Treasury stock | -¥1.31B | -¥1.31B | -¥1.31B | -¥1.91B | -¥1.4B |
EDINET (FSA Japan)
訂正有価証券報告書-第76期(2024/12/01-2025/11/30)
EDINET (FSA Japan)
有価証券報告書-第75期(2023/12/01-2024/11/30)
EDINET (FSA Japan)
訂正有価証券報告書-第74期(2022/12/01-2023/11/30)
EDINET (FSA Japan)
有価証券報告書-第73期(2021/12/01-2022/11/30)
EDINET (FSA Japan)
有価証券報告書-第72期(令和2年12月1日-令和3年11月30日)
EDINET (FSA Japan)
有価証券報告書-第71期(令和1年12月1日-令和2年11月30日)
Extracted from XBRL: 50 / Derived from other figures: 1
Spotted an error? Report it (corrections keep the original record)
Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.